...
首页> 外文期刊>Cephalalgia >Evidence for activation of the coagulation system in migraine with aura.
【24h】

Evidence for activation of the coagulation system in migraine with aura.

机译:有先兆偏头痛的凝血系统激活的证据。

获取原文
获取原文并翻译 | 示例
           

摘要

Migraine with aura has been shown to be an independent risk factor for stroke. Although the precise mechanism of migraine-related stroke is not known, risk factors for hypercoagulability have been found in migraineurs. Prothrombin factor 1.2 (F1.2) is a cleavage product of prothrombin. Elevated plasma F1.2 has been shown to be a sensitive and a specific marker of ongoing thrombin generation, and thus may serve as an indicator of hypercoagulability. In this study we determined plasma F1.2 levels in 35 patients with migraine (22 with aura and 13 without aura) and in 24 healthy age- and sex-matched volunteers. Elevated F1.2 levels were found in 11 of 22 (50%) patients with migraine with aura (1.25-3.5 nmol/l). None of the patients with migraine without aura nor any of the healthy volunteers had elevated plasma F1.2 levels (normal < 1.1 nmol/l). We conclude that prothrombin F1.2 levels are elevated in a significant number of patients with migraine with aura but not in patients with migraine without aura. This finding suggests that there is activation of the clotting system in certain patients with migraine with aura.
机译:偏头痛先兆已被证明是中风的独立危险因素。尽管尚不清楚与偏头痛相关的中风的确切机制,但在偏头痛患者中已发现高凝性的危险因素。凝血酶原因子1.2(F1.2)是凝血酶原的裂解产物。血浆F1.2升高已被证明是正在进行的凝血酶生成的敏感和特定标志物,因此可作为高凝性指标。在这项研究中,我们测定了35名偏头痛患者(22名先兆,13名无先兆)和24名年龄和性别匹配的健康志愿者的血浆F1.2水平。在22名(50%)偏头痛先兆(1.25-3.5 nmol / l)患者中,有11名(50%)发现F1.2水平升高。没有先兆偏头痛的患者或任何健康志愿者均未升高血浆F1.2水平(正常值<1.1 nmol / l)。我们得出结论,在有先兆偏头痛的患者中,凝血酶原F1.2水平升高,但没有先兆偏头痛的患者中凝血酶原F1.2水平却升高。这一发现表明,某些偏头痛先兆患者存在凝血系统的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号